参考文献/References:
[1]Camacho-Gonzalez A,Spearman PW,Stoll BJ.Neonatal infectious diseases:evaluation of neonatal sepsis[J].Pediatr Clin North Am,2013,60(2):367-389.[2]Puopolo KM,Eichenwald EC.No change in the incidence of ampicillin-resistant,neonatal,early-onset sepsis over 18 years[J].Pediatrics,2010,125(5):e1031-e1038.[3]段宝生,赵娜,梁超,等.降钙素原和超敏C反应蛋白联合检测在新生儿败血症早期诊断的价值研究[J].国际检验医学杂志,2014,24(20):2754-2755.[4]陈潇,富建华.新生儿败血症229例临床特点、病原学分布及转归分析[J].中华实用儿科临床杂志,2019,34(10):740-744.[5]Sharma D,Patel A,Soni P,et al.Leminorella sepsis in very low birth weight neonate as cause of neonatal mortality:First case report and literature review[J].The Journal of Maternal-Fetal&Neonatal Medicine,2016,6(29):1-3.[6]Sharma D,Dasi T,Murki S,et al.Kluyvera ascorbata sepsis in an extremely low birth weight infant[J].Indian J Med Microbiol,2015,33(3):437-439.[7]Shane AL,Sanchez PJ,Stoll BJ.Neonatal sepsis[J].Lancet,2017,390(10104):1770-1780.[8]高波,余加林.新生儿败血症超敏C反应蛋白诊断界值探讨[J].中国实用儿科杂志, 2012(12):902-905.[9]Mussap M,Noto A,Cibecchini F,et al.The importance of biomarkers in neonatology[J].Seminars in Fetal and Neonatal Medicine,2013,18(1):56-64.[10]Sharma D,Farahbakhsh N,Shastri S,et al.Biomarkers for diagnosis of neonatal sepsis:a literature review[J].J Matern Fetal Neonatal Med,2018,31(12):1646-1659.[11]张瑾,曲东,任晓旭,等.降钙素原对新生儿败血症病情及预后的评估[J].中华医学杂志,2018,98(16):1267-1272.[12]Lee J,Bang YH,Lee EH,et al.The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life[J].Korean Journal of Pediatrics,2017,60(1):10-16.[13]Kordek A,Loniewska B,Podraza W,et al.Usefulness of estimation of blood procalcitonin concentration versus C-reactive protein concentration and white blood cell count for therapeutic monitoring of sepsis in neonates[J].Postepy Hig Med Dosw,2014,21(68):1516-1523.[14]Wu F,Hou XQ,Sun RR,et al.The predictive value of joint detection of serum amyloid protein A,PCT,and Hs-CRP in the diagnosis and efficacy of neonatal septicemia[J].European Review for Medical and Pharmacological Sciences,2019:2313.[15]Hedegaard SS,Wisborg K,Hvas A-M.Diagnostic utility of biomarkers for neonatal sepsisa systematic review[J].Infect Dis Lond Engl,2015,47(3):117-124.[16]Hofer N,Zacharias E,Müller,et al.An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis:Current Insights and New Tasks[J].Neonatology,2012,102(1):25-36.[17]Benitz WE.Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis[J].Clin Perinatol,2010,37(2):421-438.[18]周华佳.白细胞介素-6、降钙素原及C-反应蛋白在新生儿败血症早期诊断中的价值[J].检验医学与临床,2012(19):2428-2429.[19]Ganesan P,Shanmugam P,Sattar SBA,et al.Evaluation of IL-6,CRP and hs-CRP as Early Markers of Neonatal Sepsis[J].J Clin Diagn Res JCDR,2016,10(5):DC13-DC17.[20]Murphy K,Weiner J.Use of leukocyte counts in evaluation of early-onset neonatal sepsis DC[J].Pediatr Infect Dis J,2012,31(1):16-19.[21]Gerdes JS.Clinicopathologic approach to the diagnosis of neonatal sepsis[J].Clin Perinatol,1991,18(2):361-381.[22]Hornik CP,Fort P,Clark RH,et al.Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units[J].Early Hum Dev,2012,5(88):S69-S74.[23]中华医学会儿科学分会新生儿学组,中华医学会中华儿科杂志编辑委员会.新生儿败血症诊疗方案[J].中华儿科杂志,2003,41(12):897-899.[24]Hornik CP,Benjamin DK,Becker KC,et al.Use of the complete blood cell count in early-onset neonatal sepsis[J].Pediatr Infect Dis J,2012,31(8):799-802.[25]Polin RA.Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis[J].Pediatrics,2012,129(5):1006-1015.[26]Yuan H,Huang J,Lv B,et al.Diagnosis value of the serum amyloid A test in neonatal sepsis:a meta-analysis[J].BioMed Res Int,2013(2013):520294.[27]Wilfredo Colón,Aguilera JJ,Srinivasan S.Intrinsic Stability,Oligomerization,and Amyloidogenicity of HDL-Free Serum Amyloid A[J].Advances in Experimental Medicine and Biology,2015(855):117-134.[28]Arnon S,Litmanovitz I,Regev R,et al.The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants[J].J Perinat Med,2004,32(2):176-180.[29]Arnon S,Litmanovitz I,Regev RH,et al.Serum amyloid A:an early and accurate marker of neonatal early-onset sepsis[J].J Perinatol Off J Calif Perinat Assoc,2007,27(5):297-302.[30]Pavcnik-Arnol M,Hojker S,Derganc M.Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection:comparison with procalcitonin,interleukin-6,and C-reactive protein[J].Intensive Care Med,2004,30(7):1454-1460.[31]Turner D,Hammerman C,Rudensky B,et al.Procalcitonin in preterm infants during the first few days of life:introducing an age related nomogram[J].Arch Dis Child Fetal Neonatal Ed,2006,91(4):F283-F286.[32]Behrendt D.Lipopolysaccharide binding protein in preterm infants[J].Arch Dis Child Fetal Neonatal Ed,2004,89(6):F551-F554.[33]王丽平.白介素6在新生儿败血症早期诊断的应用[J].医药论坛杂志,2002(21):4.[34]Raynor LL,Saucerman JJ,Akinola MO,et al.Cytokine screening identifies NICU patients with Gram-negative bacteremia[J].Pediatr Res,2012,71(3):261-266.[35]Mehr S,Doyle LW.Cytokines as markers of bacterial sepsis in newborn infants:a review[J].Pediatr Infect Dis J,2000,19(9):879-887.[36]Qiu X,Zhang L,Tong Y,et al.Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes:A meta-analysis[J].Medicine,2018,97(47):e13146.[37]Hou T,Huang D,Zeng R,et al.Accuracy of serum interleukin(IL)-6 in sepsis diagnosis:a systematic review and meta-analysis[J].Int J Clin Exp Med,2015,8(9):15238-15245.[38]Franz AR,Sieber S,Pohlandt F,et al.Whole blood interleukin 8 and plasma interleukin 8 levels in newborn infants with suspected bacterial infection[J].Acta Paediatrica,2004,93(5):648-653.[39]Ng PC,Lam HS.Diagnostic markers for neonatal sepsis[J].Curr Opin Pediatr,2006,18(2):125-131.[40]Boskabadi H,Maamouri G,Afshari JT,et al.Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis[J].Iran J Pediatr,2010,20(1):41-47.[41]曹霞,杨婕,李翠霞,等.血清PCT、TNF-α及sTNFR-Ⅱ在新生儿败血症中表达水平及临床意义[J].标记免疫分析与临床,2019(3):447-450.[42]Nupponen I,Andersson S,Jarvenpaa AL,et al.Neutrophil CD11b Expression and Circulating Interleukin-8 as Diagnostic Markers for Early-Onset Neonatal Sepsis[J].PEDIATRICS,2001,108(1):e12.[43]Fabriek BO,Dijkstra CD,Berg TKVD.The macrophage scavenger receptor CD163[J].Immunobiology,2005,210(2-4):0-160.[44]Dessi A,Liori B,Caboni P,et al.Monitoring neonatal fungal infection with metabolomics[J].J Matern Fetal Neonatal Med,2014,27(2):34-38.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(06):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]高程凤,孙 蕊.新生儿败血症致病菌分布及耐药性分析[J].医学信息,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
GAO Cheng-feng,SUN Rui.Distribution and Drug Resistance of Pathogenic Bacteria in Neonatal Septicemia[J].Medical Information,2018,31(06):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
[3]余世纪,谢勇丽,苏晓清.血清VDBP、IL-8、sTWEAK与尿VDBP早期诊断糖尿病肾病的价值[J].医学信息,2019,32(09):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
YU Shi-ji,XIE Yong-li,SU Xiao-qing.The Value of Serum VDBP,IL-8,sTWEAK and Urine VDBP in Early Diagnosis of Diabetic Nephropathy[J].Medical Information,2019,32(06):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
[4]王清华,易守芳,余明芳.肾移植术后药源性肾损伤生物标志物的研究[J].医学信息,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
WANG Qing-hua,YI Shou-fang,YU Ming-fang.Study on Biomarkers of Drug-induced Renal Injury after Renal Transplantation[J].Medical Information,2019,32(06):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
[5]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Medical Information,2019,32(06):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[6]林素梅,吕 聪,杨小叶,等.利奈唑胺治疗新生儿革兰阳性球菌败血症的疗效[J].医学信息,2020,33(05):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
LIN Su-mei,Lyu Cong,YANG Xiao-ye,et al.Effect of Linezolid in the Treatment of Neonatal Gram-positive Cocci Sepsis[J].Medical Information,2020,33(06):142.[doi:10.3969/j.issn.1006-1959.2020.05.045]
[7]胡 静,钟晓波,朱士胜,等.颞下颌关节骨关节病关节液的定量蛋白质组学研究[J].医学信息,2020,33(10):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]
HU Jing,ZHONG Xiao-bo,ZHU Shi-sheng,et al.Quantitative Proteomics Study on Joint Fluid of Temporomandibular Joint Osteoarthropathy[J].Medical Information,2020,33(06):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]
[8]陈朴阳,刘 涛,范凯健.类风湿性关节炎的生物标志物及其测定[J].医学信息,2020,33(15):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]
CHEN Pu-yang,LIU Tao,FAN Kai-jian.Biomarkers of Rheumatoid Arthritis and Their Determination[J].Medical Information,2020,33(06):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]
[9]高诗奇,邓代华,杨 静.成纤维细胞生长因子21抗动脉粥样硬化作用的研究[J].医学信息,2020,33(19):28.[doi:10.3969/j.issn.1006-1959.2020.19.009]
GAO Shi-qi,DENG Dai-hua,YANG Jing.Study on Anti-atherosclerosis Effect of Fibroblast Growth Factor 21[J].Medical Information,2020,33(06):28.[doi:10.3969/j.issn.1006-1959.2020.19.009]
[10]张 明.miRNA及lncRNA在糖尿病肾病中的作用机制及临床诊断应用[J].医学信息,2020,33(21):58.[doi:10.3969/j.issn.1006-1959.2020.21.017]
ZHANG Ming.The Mechanism of miRNA and lncRNA in Diabetic Nephropathy and Clinical Diagnosis Application[J].Medical Information,2020,33(06):58.[doi:10.3969/j.issn.1006-1959.2020.21.017]